# Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

> **NCT02459080** · PHASE3 · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 619 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** TD-4208
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02459080
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-08
- **Final completion:** 2016-09
- **Target enrollment:** 619 (ACTUAL)
- **Last updated:** 2022-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459080, "Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02459080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*